Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Caicun Zhou, Ying Cheng et al.|Journal of Thoracic Oncology|2021Cited by 311
Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: Overall design and results from a multicenter retrospective epidemiologic surveyJufang Shi, Jie He, Le Wang et al.|Cancer|2021Cited by 106